http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20053911-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08
filingDate 2005-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5102cecbee4a0718e807fb2debf544b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae214890821b4770c162bf06cd9220f
publicationDate 2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20053911-L
titleOfInvention Diazepine derivatives useful as LFA inhibitors.
abstract Pharmaceutically active diazepanes, such as are useful in the treatment of disorders or diseases mediated by LFA-1 / ICAM-1, LFA-1 / ICAM-2, LFA-1 / ICAM-3 or LFA-1 / JAM-1 interactions.
priorityDate 2003-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25464
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457521271
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3384
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3383
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15896
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100334824
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403975
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15898

Total number of triples: 45.